| Serial Number | 79222834 |
| Word Mark | CAELUS PHARMACEUTICALS |
| Filing Date | Thursday, June 1, 2017 |
| Status | 707 - PARTIAL SECTION 71 ACCEPTED |
| Status Date | Monday, April 7, 2025 |
| Registration Number | 5619593 |
| Registration Date | Tuesday, December 4, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 18, 2018 |
| Goods and Services | [ Medical apparatus and instruments, namely, for use in treating cardiovascular disease or diabetes, for monitoring vital signs, blood sugar levels, AGE-levels in the skin and gut/skin microbiota composition; Medical diagnostic, testing and monitoring equipment, namely, medical diagnostic equipment for detecting and monitoring blood sugar levels, AGEs and microbiome composition; testing apparatus for medical use, namely, medical devices for testing blood glucose, microbiome composition in gut and on the skin, testing AGE-levels, and for testing the levels of butyrate in breath analysis; measuring devices for medical use, namely, medical device for measuring glucose, insulin, butyrate, propionate, gut and skin microbiome; testing apparatus for medical use, namely, blood testing apparatus, apparatus for analyzing feces or respiratory gas, medical measuring devices for medical use, namely, devices for measuring microorganisms or gas; medical test kits for home monitoring of diabetes ] |
| Goods and Services | Pharmaceutical products for treating cardiometabolic disorders; dietetic foodstuffs adapted for medical use and dietetic substances, namely, dietetic foods adapted for medical use; food supplements for human beings; medical preparations and articles for the treatment of cardiometabolic disorders; [ diagnostic preparations for medical use; pharmaceutical products and natural medicines, both for the treatment of cardiometabolic disorders; vaccines; ] pharmaceutical preparations, namely, medicines [ and vaccines, ] for the prevention of diabetes mellitus [ , Crohn's disease and ulcerative colitis disease ] ; pharmaceutical preparations, namely, medicines for the treatment of diabetes mellitus, [ Crohn's disease, ulcerative colitis disease ] and metabolic syndrome being insulin resistance; dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic preparations, namely, dietary supplements; dietary food preparations, namely, dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the prevention of diabetes mellitus [ , Crohn's disease and ulcerative colitis disease ] ; dietary food preparations, namely, dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the treatment of diabetes mellitus [ , Crohn's disease, ulcerative colitis disease ] and metabolic syndrome being insulin resistance; medical preparations, namely, cultures of microorganisms for medical use, and bacterial preparations for medical use [ ; chemicals for the diagnosis of diabetes mellitus, Crohn's disease and ulcerative colitis disease; vaccine preparations for human use ] |
| NOT AVAILABLE | "PHARMACEUTICALS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 19, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Monday, April 7, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Caelus Pharmaceuticals B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | Zegveld NL-3474 KG NL |
| Party Name | Caelus Pharmaceuticals B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Party Name | Caelus Pharmaceuticals B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | NL |
| Event Date | Event Description |
| Thursday, December 14, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, December 18, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, December 19, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 19, 2017 | ASSIGNED TO EXAMINER |
| Friday, December 22, 2017 | NON-FINAL ACTION WRITTEN |
| Saturday, December 23, 2017 | APPLICATION FILING RECEIPT MAILED |
| Saturday, December 23, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 12, 2018 | REFUSAL PROCESSED BY MPU |
| Friday, January 12, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, February 15, 2018 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, February 16, 2018 | REFUSAL PROCESSED BY IB |
| Friday, July 6, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 6, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 6, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 2, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 2, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 2, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 2, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 2, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 13, 2018 | ASSIGNED TO LIE |
| Wednesday, August 29, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 29, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 29, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, September 15, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 18, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 18, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 4, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, March 4, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, March 18, 2019 | FINAL DISPOSITION PROCESSED |
| Monday, March 18, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 5, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, December 4, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Saturday, December 30, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, November 14, 2024 | TEAS SECTION 71 RECEIVED |
| Monday, April 7, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, April 7, 2025 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Monday, April 7, 2025 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Sunday, December 7, 2025 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |